Labels for J&J, AstraZeneca COVID-19 vaccines updated to include autoimmune disorder warning – CTV
November 10, 2021
BARRIE — Health Canada is updating the labels on two of the COVID-19 vaccines approved for use in Canada, to add the autoimmune disorder known as immune thrombocytopenia (ITP) as a potential side effect.
In an advisory issued Tuesday, Health Canada said it is updating the label of the Janssen (Johnson & Johnson) COVID-19 vaccine to “provide additional information about the very rare risk of ITP” and the “rare risk of venous thromboembolism (VTE)” after vaccination.
The label on the Vazxeveria vaccine made by AstraZeneca is also being updated to provide additional information about the “very rare risk” of thrombocytopenia, “including the very rare risk of ITP following vaccination,” the agency said.
According to Health Canada, “very rare cases” of ITP have been reported internationally in those who have received the vaccine from Janssen.
